Halozyme Therapeutics, Inc. (HALO)
NASDAQ: HALO · Real-Time Price · USD
63.81
-0.03 (-0.05%)
At close: Mar 31, 2025, 4:00 PM
63.11
-0.70 (-1.10%)
Pre-market: Apr 1, 2025, 7:39 AM EDT

Halozyme Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Market Capitalization
7,8586,0834,8827,6945,6595,765
Upgrade
Market Cap Growth
24.59%24.59%-36.54%35.96%-1.84%122.48%
Upgrade
Enterprise Value
8,7996,9515,9298,9405,7225,817
Upgrade
Last Close Price
63.8147.8136.9656.9040.2142.71
Upgrade
PE Ratio
18.6013.7017.3438.0614.0544.66
Upgrade
Forward PE
13.0210.389.7721.9217.8925.20
Upgrade
PS Ratio
7.975.995.8911.6612.7621.54
Upgrade
PB Ratio
21.6016.7258.2645.3128.7338.17
Upgrade
P/TBV Ratio
----28.7338.17
Upgrade
P/FCF Ratio
16.7812.9913.0832.7018.99108.87
Upgrade
P/OCF Ratio
16.4012.7012.5732.0418.90103.95
Upgrade
PEG Ratio
0.900.900.900.910.460.55
Upgrade
EV/Sales Ratio
8.676.857.1513.5412.9121.74
Upgrade
EV/EBITDA Ratio
14.0311.0914.2226.6020.6339.89
Upgrade
EV/EBIT Ratio
15.9612.6117.4330.8920.7440.33
Upgrade
EV/FCF Ratio
18.7914.8415.8837.9919.20109.86
Upgrade
Debt / Equity Ratio
4.224.2218.279.074.472.66
Upgrade
Debt / EBITDA Ratio
2.422.423.594.543.152.71
Upgrade
Debt / FCF Ratio
3.283.284.106.552.957.59
Upgrade
Asset Turnover
0.540.540.460.450.530.47
Upgrade
Inventory Turnover
1.771.772.362.672.041.72
Upgrade
Quick Ratio
6.506.505.074.547.101.11
Upgrade
Current Ratio
7.807.806.645.657.911.32
Upgrade
Return on Equity (ROE)
198.42%198.42%222.07%110.23%231.44%106.33%
Upgrade
Return on Assets (ROA)
18.16%18.16%11.89%12.28%20.47%15.74%
Upgrade
Return on Capital (ROIC)
19.61%19.61%12.78%12.98%21.16%17.11%
Upgrade
Return on Capital Employed (ROCE)
28.70%28.70%21.00%16.90%27.90%91.00%
Upgrade
Earnings Yield
5.65%7.30%5.77%2.63%7.12%2.24%
Upgrade
FCF Yield
5.96%7.70%7.65%3.06%5.27%0.92%
Upgrade
Buyback Yield / Dilution
3.56%3.56%4.56%4.21%-3.77%1.99%
Upgrade
Updated Feb 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q